Martin Oswald, Head of Operational Transformation at Travelodge, explains how a deliberate, colleague-first approach to ...

UiPath develops enterprise automation technology platforms; Robotic process automation enables digital workflow transformation; UiPath software integrates artificial i ...

UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...

UiPath Inc. reports fiscal fourth-quarter results Wednesday after market close, with investors scrutinizing whether the automation software maker’s pivot to artificial intelligence-powered "agentic ...

UiPath shares have had a tough start to the year, but the company has a big potential opportunity ahead.

We recently compiled a list of the 11 Technology Stocks with Insider Buying in 2026. UiPath, Inc. (NYSE:PATH) is among the ...

UiPath collaborates with Microsoft to help organizations accelerate security operations when applying automation to business ...

At UiPath’s Fusion London event, NFU Mutual’s automation lead explains how the UK insurer built a working agentic claims ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

UiPath stock sinks despite reporting its first-ever profit in Q4. A new buyback plan is failing to support PATH share price as well. Here's why the price action on Thursday does make sense.

UiPath (NYSE:PATH) has launched agentic AI automation solutions focused on healthcare, targeting workflows such as medical ...